Altimmune (ALT) Leases: 2019-2024
Historic Leases for Altimmune (ALT) over the last 6 years, with Dec 2024 value amounting to $1.6 million.
- Altimmune's Leases rose 351.52% to $1.6 million in Q4 2024 from the same period last year, while for Dec 2024 it was $1.6 million, marking a year-over-year increase of 351.52%. This contributed to the annual value of $1.6 million for FY2024, which is 351.52% up from last year.
- As of Q4 2024, Altimmune's Leases stood at $1.6 million, which was down 1.21% from $1.7 million recorded in Q3 2024.
- In the past 5 years, Altimmune's Leases registered a high of $1.7 million during Q2 2024, and its lowest value of $300,000 during Q1 2024.
- In the last 3 years, Altimmune's Leases had a median value of $622,500 in 2022 and averaged $815,250.
- The largest annual percentage gain for Altimmune's Leases in the last 5 years was 351.52% (2024), contrasted with its biggest fall of 44.55% (2024).
- Over the past 5 years, Altimmune's Leases (Quarterly) stood at $903,825 in 2020, then dropped by 11.71% to $798,000 in 2021, then decreased by 25.31% to $596,000 in 2022, then tumbled by 39.09% to $363,000 in 2023, then soared by 351.52% to $1.6 million in 2024.
- Its last three reported values are $1.6 million in Q4 2024, $1.7 million for Q3 2024, and $1.7 million during Q2 2024.